journal article
Open Access
May 01, 2013
Cardiac Troponin-I Concentration, Myocardial Arteriosclerosis, and Fibrosis in Dogs with Congestive Heart Failure because of Myxomatous Mitral Valve Disease
Abstract
Abstract
Background
Few previous studies have investigated the association between biomarkers and cardiac disease findings in dogs with naturally occurring myxomatous mitral valve disease (MMVD).
Aim
To investigate if histopathological changes at necropsy could be reflected by in vivo circulating concentrations of cTnI and aldosterone, and renin activity, in dogs with naturally occurring congestive heart failure because of MMVD.
Animals
Fifty privately owned dogs with MMVD and heart failure.
Methods
Longitudinal Study. Dogs were prospectively recruited and examined by clinical and echocardiographical examination twice yearly until time of death. Blood was stored for batched analysis of concentrations of cTnI and aldosterone, and renin activity. All dogs underwent a standardized necropsy protocol.
Results
cTnI were associated with echocardiographic left ventricular end-diastolic dimension (P < .0001) and proximal isovolumetric surface area radius (P < .004). Furthermore, in vivo cTnI concentrations reflected postmortem findings of global myocardial fibrosis (P < .001), fibrosis in the papillary muscles (P < .001), and degree of arterial luminal narrowing (P < .001) Aldosterone or renin activity did not reflect any of the cardiac disease variables investigated.
Conclusion and clinical importance
Cardiac fibrosis and arteriosclerosis in dogs with MMVD are reflected by circulating cTnI concentration, but not by aldosterone concentration or renin activity. Cardiac troponin I could be a valuable biomarker for myocardial fibrosis in dogs with chronic cardiac diseases.
Background
Few previous studies have investigated the association between biomarkers and cardiac disease findings in dogs with naturally occurring myxomatous mitral valve disease (MMVD).
Aim
To investigate if histopathological changes at necropsy could be reflected by in vivo circulating concentrations of cTnI and aldosterone, and renin activity, in dogs with naturally occurring congestive heart failure because of MMVD.
Animals
Fifty privately owned dogs with MMVD and heart failure.
Methods
Longitudinal Study. Dogs were prospectively recruited and examined by clinical and echocardiographical examination twice yearly until time of death. Blood was stored for batched analysis of concentrations of cTnI and aldosterone, and renin activity. All dogs underwent a standardized necropsy protocol.
Results
cTnI were associated with echocardiographic left ventricular end-diastolic dimension (P < .0001) and proximal isovolumetric surface area radius (P < .004). Furthermore, in vivo cTnI concentrations reflected postmortem findings of global myocardial fibrosis (P < .001), fibrosis in the papillary muscles (P < .001), and degree of arterial luminal narrowing (P < .001) Aldosterone or renin activity did not reflect any of the cardiac disease variables investigated.
Conclusion and clinical importance
Cardiac fibrosis and arteriosclerosis in dogs with MMVD are reflected by circulating cTnI concentration, but not by aldosterone concentration or renin activity. Cardiac troponin I could be a valuable biomarker for myocardial fibrosis in dogs with chronic cardiac diseases.
Topics
No keywords indexed for this article. Browse by subject →
References
42
[1]
Detweiler "The prevalence and types of cardiovascular disease in dogs" Ann N Y Acad Sci (1965) 10.1111/j.1749-6632.1965.tb49421.x
[2]
Das "Chronic mitral valve disease in the dog" Vet Med Small Anim Clinic (1965)
[3]
Whitney "Observations on the effect of age on the severity of heart valve lesions in the dog" J Small Anim Pract (1974) 10.1111/j.1748-5827.1974.tb06529.x
[4]
Buchanan "Chronic valvular disease (endocardiosis) in dogs" Adv Vet Sci Comp Med (1977)
[5]
Kogure "Pathology of chronic mitral valvular disease in the dog" Nihon juigaku zasshi Jap J Vet Sci (1980) 10.1292/jvms1939.42.323
[6]
Grossman "Cardiac catheterization. Indications in patients with valvular heart disease" J Am Med Assoc (1975) 10.1001/jama.1975.03240200054031
[7]
Zellner "Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure" Circ Res (1991) 10.1161/01.res.69.3.590
[8]
Ljungvall "Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease" J Vet Intern Med (2011) 10.1111/j.1939-1676.2011.0774.x
[9]
Schaper "Angiogenesis in the adult heart" Basic Res Cardiol (1991)
[10]
Beltrami "Structural basis of end-stage failure in ischemic cardiomyopathy in humans" Circulation (1994) 10.1161/01.cir.89.1.151
[11]
Veinot "Early apoptosis in human myocardial infarcts" Hum Pathol (1997) 10.1016/s0046-8177(97)90039-3
[12]
Sabbah "Programmed cell death in the progression of heart failure" Ann Med (1998) 10.1080/13652060.1998.12527713
[13]
Jubb (1992)
[14]
Falk "Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease" Cardiovasc Pathol (2006) 10.1016/j.carpath.2006.04.003
[15]
Sabbah "A canine model of chronic heart failure produced by multiple sequential coronary microembolizations" Am J Physiol (1991)
[16]
Jönsson "Coronary arterial lesions and myocardial infarcts in the dog. A pathologic and microangiographic study" Acta Vet Scand (1972)
[17]
Katz (2001)
[18]
van der Laarse "Hypothesis: Troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure" Cardiovasc Res (2002) 10.1016/s0008-6363(02)00534-5
[19]
Horwich "Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure" Circulation (2003) 10.1161/01.cir.0000084543.79097.34
[20]
La Vecchia "Cardiac troponin I as diagnostic and prognostic marker in severe heart failure" J Heart Lung Transplant (2000) 10.1016/s1053-2498(00)00120-0
[21]
Eggers "Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making" Clin Chem (2009) 10.1373/clinchem.2007.101683
[22]
Schulz "Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease" Am J Cardiol (2007) 10.1016/j.amjcard.2007.03.096
[23]
Ljungvall "Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs" J Vet Intern Med (2010) 10.1111/j.1939-1676.2009.0428.x
[24]
Pedersen "Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency" J Vet Intern Med (1995) 10.1111/j.1939-1676.1995.tb01092.x
[25]
Häggström "Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs" Am J Vet Res (1997) 10.2460/ajvr.1997.58.01.77
[26]
Smith "Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates" Circulation (1997) 10.1161/01.cir.95.1.163
[27]
Ooi "Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology" Clin Chem (2000) 10.1093/clinchem/46.3.338
[28]
O'Brien "Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals" Lab Animal (2006) 10.1258/002367706776319042
[29]
Schultze "Ultrasensitive cross-species measurement of cardiac troponin-I using the Erenna immunoassay system" Toxicol Pathol (2008) 10.1177/0192623308322016
[30]
Falk "Associations between cardiac pathology and clinical, echocardiographic and electrocardiographic findings in dogs with chronic congestive heart failure" Vet J (2010) 10.1016/j.tvjl.2010.04.016
[31]
Buchanan "Vertebral scale system to measure heart size in radiographs" Vet Clinics North Am Small Anim Pract (2000) 10.1016/s0195-5616(00)50027-8
[32]
Moesgaard "Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation" J Vet Intern Med (2005) 10.1111/j.1939-1676.2005.tb02750.x
[33]
Poulsen "An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody" J Clin Endocrinol Metab (1974) 10.1210/jcem-39-5-816
[34]
Pedersen "Some effects of a low sodium diet high in potassium on the renin-angiotensin system and plasma electrolyte concentrations in normal dogs" Acta Vet Scand (1994) 10.1186/bf03548340
[35]
Hansson "Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavalier King Charles Spaniels with and without left atrial enlargement" Vet Radiol Ultrasound (2002) 10.1111/j.1740-8261.2002.tb01051.x
[36]
Kittleson (1989)
[37]
Cornell "Della Torre P, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs" J Vet Intern Med (2004) 10.1111/j.1939-1676.2004.tb02551.x
[38]
Choi "Quantification of mitral regurgitation using proximal isovelocity surface area method in dogs" J Vet Sci (2004) 10.4142/jvs.2004.5.2.163
[39]
Pomerance "Heart valve changes common to man and dog: A comparative study" Cardiovasc Res (1970) 10.1093/cvr/4.1.61
[40]
Detweiler "Spontaneous and induced arterial disease in the dog: pathology and pathogenesis" Toxicol Pathol (1989) 10.1177/019262338901700105
[41]
Caulfield "Myocardial connective tissue alterations" Toxicol Pathol (1990) 10.1177/0192623390004part_107
[42]
Sabbah "Progression of heart failure: A role for interstitial fibrosis" Mol Cell Biochem (1995) 10.1007/bf00944780
Metrics
33
Citations
42
References
Details
- Published
- May 01, 2013
- Vol/Issue
- 27(3)
- Pages
- 500-506
- License
- View
Authors
Funding
Danish Council of Medical Sciences
Karin Forsberg's Foundation
Agria animal insurance company research foundation
Cite This Article
T. Falk, I. Ljungvall, N.E. Zois, et al. (2013). Cardiac Troponin-I Concentration, Myocardial Arteriosclerosis, and Fibrosis in Dogs with Congestive Heart Failure because of Myxomatous Mitral Valve Disease. Journal of Veterinary Internal Medicine, 27(3), 500-506. https://doi.org/10.1111/jvim.12075
Related
You May Also Like
Passive Transfer of Colostral Immunoglobulins in Calves
Dusty M Weaver, Jeff W Tyler · 2000
627 citations
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
Mark J. Acierno, Scott Brown · 2018
463 citations
Allometric Scaling of M-Mode Cardiac Measurements in Normal Adult Dogs
Craig C Cornell, Mark D Kittleson · 2004
403 citations
The renin-angiotensin-aldosterone system and its suppression
Marisa K. Ames, Clarke E. Atkins · 2019
364 citations
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease
M. Borgarelli, P. Savarino · 2008
282 citations